Nurse Practitioner in Harrington, DE Accepting Medicare

5 Nurse Practitioner nurses found. Showing 1 - 5

Mrs. Mona T Orsini, CRNP, MSN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 East St, Harrington, DE 19952 Phone: 302-786-7800

Patricia M Grady, CRNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1000 Midway Dr Ste 3, Harrington, DE 19952 Phone: 800-818-8680    Fax: 800-818-8680

Sylvia Regina Judd, N.P. Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 1 East St, Harrington, DE 19952 Phone: 833-886-2277

Michelle Devern, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 16681 S Dupont Hwy, Harrington, DE 19952 Phone: 302-398-8704    Fax: 302-398-8818

Mrs. Emanie Elysee Dorival, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 Midway Dr Ste 3, Harrington, DE 19952 Phone: 800-818-8680    Fax: 800-818-8680

News Archive

Intra-Cellular Therapies ITI-007 Phase Ib/II clinical trial for schizophrenia meets primary endpoint

Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.

New virtual gaming platform developed for pharmacy education

Education Management Solutions, LLC, a leading innovator of simulation management technologies, today announced a groundbreaking new virtual gaming platform for pharmacy and clinical therapeutics education.

Bacteriophages can tackle drug-resistant bacterial infections

Viruses that can target and destroy bacteria have the potential to be an effective strategy for tackling hard-to-treat bacterial infections. The development of such novel therapies is being accelerated in response to growing antibiotic resistance, says Dr David Harper at the Society for General Microbiology's Spring Conference in Dublin.

Increased risk of uterine cancer linked to 24 gene variants

The risk of uterine endometrial cancer is increased by 24 gene variants that code for different cellular processes such as cell growth and death, gene regulation, and estrogen metabolism, according to a comprehensive review published in the Journal of Medical Genetics.

InNexus receives $116,760 cash grant under QTDP program to develop DXL anti-cancer antibodies

InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.

Read more Medical News

› Verified 3 days ago